Orion Diagnostica's co-operation negotiations in Oulu completed

Orion Diagnostica's co-operation negotiations in Oulu completed

ID: 545992

(Thomson Reuters ONE) -



ORION CORPORATION         PRESS RELEASE 2 JUNE 2017 at 11.06 a.m.
EEST


Orion Diagnostica's co-operation negotiations in Oulu completed

The co-operation negotiations which were initiated in April in Orion Diagnostica
Oy, a subsidiary of Orion Corporation focusing on diagnostic tests, have been
completed.

As a result, a decision has been made to terminate the operations of Orion
Diagnostica Oy in Oulu and move the operations entirely to Espoo. The
negotiations concerned 14 employees, who will primarily be offered a transfer to
Orion Diagnostica's location in Espoo.

Orion Diagnostica Oy received a notice of termination from its landlord in April
to terminate the lease agreement of Orion Diagnostica's premises in Oulu.  For
this reason, the operations of Orion Diagnostica Oy in the current premises will
end by the end of September 2017 at the latest. Orion Diagnostica Oy gave a
negotiation proposal, as laid down in the Finnish Act on Co-operation within
Undertakings, in April on reorganising operations and possible personnel
reductions in Oulu. The negotiations concerned 14 employees.




Contact person:
Kaisa Tarkkanen, President, Orion Diagnostica Oy
tel. +358 10 426 3268


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish pharmaceutical company - a builder of
well-being. Orion develops, manufactures and markets human and veterinary
pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The
company is continuously developing new drugs and treatment methods. The core
therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS)
disorders, oncology and respiratory for which Orion developes inhaled Easyhaler®




pulmonary drugs. Orion's net sales in 2016 amounted to EUR 1,074 million and the
company had about 3,500 employees. Orion's A and B shares are listed on Nasdaq
Helsinki. Founded in 1917, Orion celebrates its centennial anniversary in 2017.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Orion Oyj via GlobeNewswire




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Odfjell SE - Successful placement of new unsecured bond issue Zealand to present at two international healthcare investor conferences in June 2017
Bereitgestellt von Benutzer: hugin
Datum: 02.06.2017 - 10:06 Uhr
Sprache: Deutsch
News-ID 545992
Anzahl Zeichen: 2711

contact information:
Town:

Espoo



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 210 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Orion Diagnostica's co-operation negotiations in Oulu completed"
steht unter der journalistisch-redaktionellen Verantwortung von

Orion Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Orion Oyj



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z